A perspective on the use of concentration-QT modeling in drug development

J Clin Pharmacol. 2008 Jan;48(1):9-12. doi: 10.1177/0091270007311115.
No abstract available

Publication types

  • Comment

MeSH terms

  • Dose-Response Relationship, Drug
  • Drugs, Investigational / adverse effects*
  • Guidelines as Topic
  • Humans
  • Long QT Syndrome / chemically induced*
  • Long QT Syndrome / diagnosis
  • Risk Assessment / methods

Substances

  • Drugs, Investigational